Detection and abundance of SARS-CoV-2 in wastewater in Liechtenstein, and the estimation of prevalence and impact of the B.1.1.7 variant.


Journal

Journal of water and health
ISSN: 1477-8920
Titre abrégé: J Water Health
Pays: England
ID NLM: 101185420

Informations de publication

Date de publication:
Jan 2022
Historique:
entrez: 31 1 2022
pubmed: 1 2 2022
medline: 3 2 2022
Statut: ppublish

Résumé

The new coronavirus 2 (SARS-CoV-2) is known to be also shed through feces, which makes wastewater-based surveillance possible, independent of symptomatic cases and unbiased by any testing strategies and frequencies. We investigated the entire population of the Principality of Liechtenstein with samples from the wastewater treatment plant Bendern (serving all 39,000 inhabitants). Twenty-four-hour composite samples were taken once or twice a week over a period of 6 months from September 2020 to March 2021. Viral RNA was concentrated using the PEG centrifugation method followed by reverse transcription quantitative PCR. The aim of this research was to assess the suitability of SARS-CoV-2 fragments to relate the viral wastewater signal to the incidences and assess the impact of the emerging B.1.1.7. variant. The viral load in the wastewater peaked at almost 9 × 10

Identifiants

pubmed: 35100159
pmc: wh_2021_180
doi: 10.2166/wh.2021.180
doi:

Substances chimiques

Waste Water 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114-125

Auteurs

R Markt (R)

Department of Microbiology, Universität Innsbruck, Technikerstraße 25d, Innsbruck 6020, Austria E-mail: rudolf.markt@uibk.ac.at.

L Endler (L)

Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, Vienna 1090, Austria.

F Amman (F)

Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, Vienna 1090, Austria.

A Schedl (A)

Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, Vienna 1090, Austria.

T Penz (T)

Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, Vienna 1090, Austria.

M Büchel-Marxer (M)

Ministry of Social Affairs and Culture, Peter-Kaiser-Platz 1, Vaduz 9490, Principality of Liechtenstein.

D Grünbacher (D)

Unit of Environmental Engineering, Department of Infrastructure, Universität Innsbruck, Technikerstraße 13, Innsbruck 6020, Austria.

M Mayr (M)

Department of Microbiology, Universität Innsbruck, Technikerstraße 25d, Innsbruck 6020, Austria E-mail: rudolf.markt@uibk.ac.at.

E Peer (E)

Department of Microbiology, Universität Innsbruck, Technikerstraße 25d, Innsbruck 6020, Austria E-mail: rudolf.markt@uibk.ac.at.

M Pedrazzini (M)

Ministry of Social Affairs and Culture, Peter-Kaiser-Platz 1, Vaduz 9490, Principality of Liechtenstein.

W Rauch (W)

Unit of Environmental Engineering, Department of Infrastructure, Universität Innsbruck, Technikerstraße 13, Innsbruck 6020, Austria.

A O Wagner (AO)

Department of Microbiology, Universität Innsbruck, Technikerstraße 25d, Innsbruck 6020, Austria E-mail: rudolf.markt@uibk.ac.at.

F Allerberger (F)

Austrian Agency for Health and Food Safety (AGES), Vienna 1220, Austria.

A Bergthaler (A)

Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, Vienna 1090, Austria.

H Insam (H)

Department of Microbiology, Universität Innsbruck, Technikerstraße 25d, Innsbruck 6020, Austria E-mail: rudolf.markt@uibk.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH